By the Weight Loss Provider Guide editorial team. Last verified: May 14, 2026 · Last updated: May 14, 2026

SHED vs Henry Meds (2026): The Honest Side-by-Side That Ends the Comparison

The short answer (before you scroll)

For most people choosing between SHED and Henry Meds in 2026, SHED is the better default. It offers more compounded GLP-1 formats (injections, sublingual drops, lozenges, oral liposomal tablets), it lists FDA-approved brand-name pathways (Wegovy®, Zepbound®, and Foundayo®) as a separate add-on, it’s available in all 50 states, and its compounded semaglutide injection starts at $175/month on its semaglutide product page. Henry Meds is the better fit for a narrower reader: someone who wants a simpler, medication-forward telehealth setup, in one of the 41 states where Henry operates, and who is fine with month-to-month flexibility or fully understands the multi-month prepay terms before committing.

Three conditions change the answer:

• You live in Alabama, Alaska, Arkansas, Hawaii, Louisiana, Mississippi, Missouri, South Carolina, or West Virginia. Henry doesn’t operate in those states per multiple third-party verified reviewer sources. SHED says it’s available in all 50 states. Pick SHED.
• You want flat pricing that doesn’t change as your dose goes up. Both SHED and Henry use product- and program-tiered pricing. Eden’s flat-rate model is the better fit.
• You want FDA-approved Wegovy®, Zepbound®, or Foundayo® as your main path with insurance navigation. Neither is the cleanest primary. Ro carries the full FDA-approved menu at manufacturer-matched cash pricing, plus a free insurance coverage checker and a concierge that handles prior-authorization paperwork.

That’s the verdict. Now here’s why — with the actual prices, the cancellation terms, the BBB complaint reality for both companies, and the FDA picture from May 2026 you won’t find on most of the comparison pages you’ve already opened.

At-a-glance: SHED vs Henry Meds in 30 seconds

Sources: SHED product pages on tryshed.com and shedrx.com; Henry Meds program pages on henrymeds.com; BBB profiles for both companies; Trustpilot for both companies. Verified May 14, 2026.

What we actually verified (and what we didn’t)

We pulled every price in this article directly from each provider’s own public pages on May 14, 2026, then cross-checked against multiple third-party reviewers. Where SHED’s own pages showed two starting prices (the semaglutide injection product page says “as low as $175,” the broader GLP-1 injection page says “starting at $199”), we list both — the price you see at checkout depends on the product, dose, and state you select.

How much will you actually pay? (Not the sticker — the real number)

Answer in one paragraph: SHED’s verified starting prices are lower for compounded semaglutide injection and compounded tirzepatide injection. Henry’s starting prices are lower for some non-semaglutide or non-injectable categories — its premium non-injectable semaglutide tablets/drops and its compounded liraglutide both start at $179/month. SHED’s compounded semaglutide injection starts at $175 on its semaglutide product page; SHED’s GLP-1 lozenges are $199/month. Henry’s standard compounded semaglutide injection is $297/month month-to-month, dropping to about $197/month on a 12-month prepay. Neither uses a simple per-dose-tier escalation across every product — they use a mix of product, term, and program tiers, so confirm the actual price at checkout for your dose, route, state, and term before paying.

The 12-month true cost matrix

The sticker price on the homepage is what you pay your first month at a starting dose or on a specific program tier. Multiply across a year and the answer changes.

Prices verified May 14, 2026 from tryshed.com, shedrx.com, and henrymeds.com. Re-verify at the actual checkout flow before paying.

What this math actually shows

1. SHED has the lowest verified starting price for compounded semaglutide injection ($175) and compounded tirzepatide injection ($245). Nobody else on page 1 leads with the $175 figure from SHED’s own semaglutide product page.
2. Henry’s “$179/month” homepage promise applies to specific programs — liraglutide and premium non-injectable semaglutide tablets/drops. It does not apply to the compounded semaglutide injection most patients sign up for. The standard month-to-month rate for that injection is $297. Going in expecting $179 is the most common mistake new Henry patients make.
3. Henry’s 12-month prepay is mathematically cheaper than SHED on compounded semaglutide injection — about $197/month effective. But the prepay is generally non-refundable except for medically required discontinuation supported by clinical documentation. If you’re 100% certain you’ll stay on the medication for a year, the prepay math works. If there’s a real chance you’ll stop for any reason other than a documented medical issue, it’s a worse deal.

So which is cheaper?

• Cheapest compounded semaglutide injection at month one: SHED at $175
• Cheapest compounded semaglutide injection over a confident 12 months: Henry's 12-month prepay at roughly $197/month effective
• Cheapest compounded tirzepatide injection: SHED at $245 (vs Henry's $449 standard injectable)
• Cheapest oral compounded tirzepatide tablets over a confident 12 months: Henry's annual prepay at roughly $234/month effective
• Cheapest needle-free SHED format: GLP-1 lozenges at $199/month flat
• Cheapest if you want flat pricing that doesn’t change with dose or program tier: Neither — go Eden

Formats: compounded options on each platform (and why it matters)

Answer in one paragraph: SHED publicly lists more compounded delivery formats — weekly semaglutide and tirzepatide injections, sublingual drops, dissolvable lozenges, and oral liposomal tablets. Henry Meds publicly lists weekly compounded semaglutide injection, daily compounded liraglutide injection, oral dissolving semaglutide tablets, sublingual semaglutide drops, and oral dissolving tirzepatide tablets. SHED separately offers an FDA-approved brand-name pathway (Wegovy®, Zepbound®, Foundayo®) through a paid SHED membership — these are not compounded products. Henry does not offer FDA-approved brand-name medication.

Why format optionality matters

The number-one reason people stop taking a GLP-1 in the first 8 weeks is side effects: nausea, GI issues, fatigue, or injection-site reactions. When that happens, there are three choices: push through, stop entirely, or switch to a different delivery format under provider review. Switching format is the one that actually keeps people on treatment. On SHED, you can ask your provider about switching from injection to drops, lozenges, or oral liposomal tablets. Henry’s menu is narrower: you can move between Henry’s available forms, but Henry doesn’t offer the lozenge format, doesn’t offer the liposomal oral tablet, and doesn’t offer FDA-approved brand-name medication if your situation changes.

Cancellation: the single biggest difference in your downside

Answer in one paragraph: SHED requires a 2-month minimum commitment on most subscriptions, with cancellation submitted at least 72 hours before your next billing date. Henry Meds is month-to-month for its standard plan with simple cancellation effective at the end of the current billing period. Henry’s 6-month and 12-month prepay plans are generally non-refundable — Henry’s policy states a prorated refund of unused prepaid subscription fees may be available for medically required discontinuation supported by clinical documentation, but medication already dispensed is non-refundable.

Cancellation Friction Score

Lower score = easier to leave. Verified May 14, 2026.

What both BBB profiles actually say

This is not a “one of them is a scam” situation. Both companies have real volume and real complaints. The difference matters for your decision in two ways:

1. Henry’s complaints concentrate in billing and cancellation — which is exactly the place a prepay commitment exposes you. If you’re considering Henry’s 6 or 12-month prepay, read the refund policy in writing first.
2. SHED’s complaints are spread across a wider category mix — product, delivery, service, and billing — without the same concentration on prepay refundability. The 2-month minimum caps your contract exposure.

The 2026 FDA reality (what changed, what didn’t)

Answer in one paragraph: Both SHED and Henry Meds sell compounded GLP-1 medications, which are not FDA-approved. The FDA resolved the semaglutide shortage in February 2025 and the tirzepatide shortage in late 2024. Enforcement grace periods for 503B outsourcing facilities ended in May 2025. As of May 14, 2026, 503A patient-specific compounding remains legal — state-licensed pharmacies can still fill an individual prescription for compounded semaglutide or tirzepatide. On April 30, 2026, the FDA proposed barring 503B bulk-compounding of semaglutide, tirzepatide, and liraglutide entirely; a public comment period runs through June 29, 2026. That proposal is not yet final.

What changed in 2026

Compounded GLP-1 is legal and available in May 2026. But the long-term reliable path is FDA-approved medication — Wegovy®, Zepbound®, or Foundayo® through a provider that carries the full FDA-approved menu and offers insurance navigation.

Are SHED and Henry Meds legit?

Answer in one paragraph: Both are legally operating U.S. telehealth platforms. Both use licensed clinicians, state-licensed compounding pharmacies, and the same general telehealth-plus-compounded-pharmacy model. “Legit” in this category does not mean every medication is FDA-approved — both companies prescribe compounded medications that have not been FDA-reviewed. The honest legitimacy questions are: who is the clinician, what is the medication, which pharmacy is filling it, and what are the contract terms.

How to vet either provider before paying

Both companies pass a basic legitimacy check. The honest path forward is the seven questions at the bottom of this page applied to whichever provider you’re considering. Neither appears on the FDA’s published warning-letter database as of our verification date — confirm that on the FDA database yourself on the day you sign up, since this landscape is fluid.

What real members actually say

Answer in one paragraph: Trustpilot leans positive for both — Henry holds about 4.5 stars across 12,000+ reviews, SHED trends mixed-positive at lower review volume. Reddit and BBB feedback for both is genuinely split. Positive reviews praise medication availability, fast intake, and clinician quality. Negative reviews on Henry concentrate on billing, auto-renewal, and prepay refundability. Negative reviews on SHED concentrate on dose-tier or program-tier pricing surprises, support response time, and the guarantee qualification rules.

Tirzepatide specifically: SHED vs Henry Meds

Answer in one paragraph: For compounded tirzepatide, SHED is materially cheaper at the entry point. SHED’s compounded tirzepatide injection starts at $245/month. Henry Meds’ injectable compounded tirzepatide is $449/month standard per third-party verified reviewers, and Henry’s compounded oral dissolving tirzepatide tablets are $349/month standard — dropping to about $234/month effective on a 12-month prepay. For FDA-approved Zepbound® or Mounjaro®, neither carries them as a cash-pay primary path — Ro carries Zepbound® at manufacturer-matched cash pricing.

Which provider wins for your specific situation

Five segments, one winner per segment. This is the section that ends the search.

If one of those just disqualified SHED or Henry, take our 60-second matching quiz and we’ll route you to the right path.

7 questions to ask before you pay either provider

A reputable provider will answer all of these clearly.

1. 1

   Is this compounded medication, or an FDA-approved brand?

   These are not the same. Compounded products are not FDA-reviewed.

2. 2

   Which licensed clinician is reviewing my case?

   Ask for the prescriber's name and state license.

3. 3

   Which pharmacy is filling my prescription?

   Both SHED and Henry use networks. Ask which one specifically. Is it state-licensed? Is it 503A or 503B?

4. 4

   What’s the exact dose, concentration, and route?

   Mg per dose. Volume per dose. How you administer it.

5. 5

   What will I pay after the first month?

   Some starter prices apply only to specific programs or doses. Get the maintenance price in writing.

6. 6

   What's the minimum commitment and the cancellation deadline?

   SHED has a 2-month minimum; Henry has prepay structures. Know what you’re agreeing to.

7. 7

   What's the refund policy for non-approval or medically required discontinuation?

   A reputable provider has clear refund language for both scenarios.

If a provider dodges any of these, that’s your signal.

SHED vs Henry Meds: Frequently Asked Questions

How we built this comparison

We compared SHED and Henry Meds across nine factors using a hierarchy of primary and authoritative sources. The providers’ own current pages are the primary record. Where third-party reviewers reported different numbers, we used the provider’s page and disclosed the disagreement.

The bottom line

For most readers comparing SHED vs Henry Meds in May 2026, SHED is the better default — more compounded formats, all 50 states, an optional FDA-approved brand-name pathway, and lower entry prices on the two highest-evidence compounded formats. Henry Meds is the right pick for a narrower reader: someone in the 41 Henry states who wants compounded semaglutide injection at the lowest 12-month-prepay effective rate, or compounded oral dissolving tirzepatide tablets on annual prepay, and who fully understands the prepay refund terms. For FDA-approved brand-name medication or insurance navigation, Ro is the right primary path. For flat-rate compounded GLP-1 pricing that doesn’t change as your dose or program tier changes, Eden wins.

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We earn affiliate commission when readers choose SHED, Eden, Ro, or other partners. We do not earn from Henry Meds. Our editorial framework picks winners by evidence and reader fit, not payout. Pricing, plan availability, shipping, cancellation rules, and FDA policy can change. We re-verify commercial facts monthly and regulatory facts at least quarterly. Last verified: May 14, 2026.

This article is informational and is not medical advice. Compounded medications are not FDA-approved, are not generics, and have not been FDA-reviewed for safety, effectiveness, or quality. Talk to a licensed clinician before starting any GLP-1 program.